RSF REBELS TO BE ELIMINATED COMPLETELY, NO TALKS TO BE HELD: SUDAN'S COMMANDER-IN-CHIEF. (PHOTO).

Image
 RSF Rebels to Be Eliminated Completely, No Talks to Be Held: Sudan's Commander-in-Chief The country will not hold negotiations with the rebels or those who support or cooperate with them, Abdel Fattah al-Burhan said at a ceremony honoring the former chief of staff and members of the General Staff. The Sudanese Armed Forces maintain their ongoing campaign to decisively defeat the terrorists and rid the country of the scourge of rebellion, he noted, Sputnik reported. For his part, Chief of Staff Yasser Abdelrahman Al-Atta pledged to fulfill his duty to the Sudanese people, stressing that the military will continue its march toward victory until full sovereignty is restored across Sudan's national territory.

KENYA HAILS FIRST ROLLOUT OF HIV PREVENTION DRUG LENACAPAVIR. (PHOTO).


 Kenya hails first rollout of HIV prevention drug Lenacapavir


Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday.


Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system.


"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the rollout, AFP reported.


Kenya was among nine African countries selected last year to introduce lenacapavir, which has already been introduced in South Africa, Eswatini and Zambia since December.


There are roughly 1.3 million people living with HIV in Kenya, with the highest burden among those aged 15 to 24.


‘Renewed strength’


"Many of our young people still face the risk of infection... this innovation gives us renewed strength in our national fight against HIV," Duale, said adding that the drug will be free to those receiving it.


Last week, Kenya received its first batch of 21,000 doses through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS.


Lenacapavir offers greater privacy compared to regularly visits to health clinics for treatment, said Carol Njomo, a community health worker in Nairobi's Kawangware area, where the first doses were administered.


"This is an added protection," said Samson Mutua, 27, the first person to receive the injection.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).